# Park Dental Partners, Inc.: financial statements, quarterly

PARK · Nasdaq · CIK 2069604 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/park.md) · [Financials](/companies/park/financials.md) · [Filings](/companies/park/filings.md) · [Insiders](/companies/park/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/park/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [59.0](/filings/0001104659-26-061216.md) | [63.0](/filings/0001104659-26-095983.md) | [62.7](/filings/0001104659-26-061216.md) | [66.2](/filings/0001104659-26-095983.md) |
| Cost of revenue | $m | [49.2](/filings/0001104659-26-061216.md) | [51.1](/filings/0001104659-26-095983.md) | [56.3](/filings/0001104659-26-061216.md) | [56.7](/filings/0001104659-26-095983.md) |
| Gross profit | $m | [9.9](/filings/0001104659-26-061216.md) | [11.9](/filings/0001104659-26-095983.md) | [6.4](/filings/0001104659-26-061216.md) | [9.5](/filings/0001104659-26-095983.md) |
| Operating income | $m | [2.6](/filings/0001104659-26-061216.md) | [4.2](/filings/0001104659-26-095983.md) | [(1.9)](/filings/0001104659-26-061216.md) | [1.3](/filings/0001104659-26-095983.md) |
| Income tax | $m | [0.6](/filings/0001104659-26-061216.md) | [1.2](/filings/0001104659-26-095983.md) | [(1.6)](/filings/0001104659-26-061216.md) | [(0.2)](/filings/0001104659-26-095983.md) |
| Net income | $m | [1.6](/filings/0001104659-26-095983.md) | [2.6](/filings/0001104659-26-095983.md) | [(0.4)](/filings/0001104659-26-095983.md) | [1.3](/filings/0001104659-26-095983.md) |
| Diluted EPS | $ per share | [0.88](/filings/0001104659-26-061216.md) | [1.45](/filings/0001104659-26-095983.md) | [(0.09)](/filings/0001104659-26-061216.md) | [0.22](/filings/0001104659-26-095983.md) |
| Basic EPS | $ per share | [0.88](/filings/0001104659-26-061216.md) | [1.45](/filings/0001104659-26-095983.md) | [(0.09)](/filings/0001104659-26-061216.md) | [0.30](/filings/0001104659-26-095983.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [25.2](/filings/0001104659-26-095983.md) | [24.4](/filings/0001104659-26-061216.md) | [24.4](/filings/0001104659-26-095983.md) |
| Current assets | $m | not reported | not reported | not reported | [37.9](/filings/0001104659-26-095983.md) | [37.7](/filings/0001104659-26-061216.md) | [39.6](/filings/0001104659-26-095983.md) |
| Total assets | $m | not reported | not reported | not reported | [178](/filings/0001104659-26-095983.md) | [180](/filings/0001104659-26-061216.md) | [186](/filings/0001104659-26-095983.md) |
| Current liabilities | $m | not reported | not reported | not reported | [35.7](/filings/0001104659-26-095983.md) | [35.3](/filings/0001104659-26-061216.md) | [35.3](/filings/0001104659-26-095983.md) |
| Total liabilities | $m | not reported | not reported | not reported | [156](/filings/0001104659-26-095983.md) | [154](/filings/0001104659-26-061216.md) | [156](/filings/0001104659-26-095983.md) |
| Long-term debt | $m | not reported | not reported | not reported | [10.1](/filings/0001104659-26-095983.md) | [9.6](/filings/0001104659-26-061216.md) | [9.1](/filings/0001104659-26-095983.md) |
| Current portion of debt | $m | not reported | not reported | not reported | [1.9](/filings/0001104659-26-095983.md) | [1.9](/filings/0001104659-26-061216.md) | [1.9](/filings/0001104659-26-095983.md) |
| Shareholders' equity | $m | [(4.3)](/filings/0001104659-26-095983.md) | [(2.9)](/filings/0001104659-26-095983.md) | [(0.6)](/filings/0001104659-26-095983.md) | [21.8](/filings/0001104659-26-095983.md) | [25.4](/filings/0001104659-26-095983.md) | [29.8](/filings/0001104659-26-095983.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [5,859](/filings/0001104659-26-061216.md) | [3,374 d](/filings/0001104659-26-095983.md) | [5,026](/filings/0001104659-26-061216.md) | [4,690 d](/filings/0001104659-26-095983.md) |
| Capital expenditure | $k | [2,420](/filings/0001104659-26-061216.md) | [1,600 d](/filings/0001104659-26-095983.md) | [2,305](/filings/0001104659-26-061216.md) | [2,447 d](/filings/0001104659-26-095983.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [1,783](/filings/0001104659-26-061216.md) | [1,773](/filings/0001104659-26-095983.md) | [4,383](/filings/0001104659-26-061216.md) | [6,235](/filings/0001104659-26-095983.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,755,282 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001104659-26-095983.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.